Breaking News Instant updates and real-time market news.

PEP

PepsiCo

$114.83

-0.15 (-0.13%)

, SODA

Acquired by PEP

$142.14

12.25 (9.43%)

16:23
08/20/18
08/20
16:23
08/20/18
16:23

Fly Intel: Wall Street's top stories for Monday

Stocks opened higher as the rally that began last week spilled over to today. The averages diverged at the open, with the Dow moving higher and the Nasdaq lagging, but by midday the major averages were green across the board. The S&P crept closer to an all-time high, falling just short of a new record. ECONOMIC EVENTS: In the U.S., no economic reports of note were released. COMPANY NEWS: PepsiCo (PEP) announced a deal to buy SodaStream (SODA) for $144 per share in cash in a $3.2B transaction that likely represents the last big bet being placed by outgoing CEO Indra Nooyi. PepsiCo's "strong distribution capabilities, global reach, R&D, design and marketing expertise, combined with SodaStream's differentiated and unique product range will position SodaStream for further expansion and breakthrough innovation," the companies stated. SodaStream shares closed 9.4% higher at $142.11 after the announcement, while Pepsi shares were little changed... In other M&A news, Tyson Food (TSN) announced it has reached a definitive agreement to buy Keystone Foods, which supplies chicken, beef, fish and pork to quick-service restaurant chains including McDonald's (MCD), from Marfrig Global Foods for $2.16B in cash... JPMorgan analyst Ryan Brinkman lowered his price target on Tesla (TSLA) shares to $195 from $308 as he reverts back to valuing the shares on the basis of fundamentals alone. While the analyst acknowledged that Tesla does appear to be exploring a going private transaction, he now believes that such a process appears much less developed than he had earlier presumed, suggesting formal incorporation into his valuation analysis seems premature at this time. Additionally, Fox Business' Charles Gasparino reported that Tesla's lawyers believe that the SEC is "under pressure" to expedite its investigation of the car maker. MAJOR MOVERS: Among the noteworthy gainers was China Biologic (CBPO), which rose 9% after a consortium of investors proposed to acquire the company for $118 per share. Also higher was Nike (NKE), which gained 3% after Susquehanna analyst Sam Poser upgraded the stock to Positive and Piper Jaffray analyst Erinn Murphy upgraded the stock to Overweight. Among the notable losers was Lannett (LCI), which plunged 60% after it reported preliminary Q4 results and said it will not renew its contract with Jerome Stevens Pharmaceuticals. Also lower were Class A shares of News Corp. (NWSA), which fell 2.4% after Andrew McLeod downgraded the stock to Underweight from Equal Weight. INDEXES: The Dow rose 89.37, or 0.35%, to 25,758.69, the Nasdaq gained 4.68, or 0.06%, to 7,821.01, and the S&P 500 advanced 6.92, or 0.24%, to 2,857.05.

PEP

PepsiCo

$114.83

-0.15 (-0.13%)

SODA

Acquired by PEP

$142.14

12.25 (9.43%)

TSLA

Tesla

$308.50

3.17 (1.04%)

LCI

Lannett

$5.30

-8.2 (-60.74%)

TSN

Tyson Foods

$63.40

1 (1.60%)

MCD

McDonald's

$161.67

0.51 (0.32%)

CBPO

China Biologic

$99.83

7.77 (8.44%)

NWSA

News Corp.

$13.57

-0.33 (-2.37%)

NKE

Nike

$82.16

2.43 (3.05%)

  • 20

    Aug

  • 20

    Aug

  • 28

    Aug

  • 12

    Sep

  • 24

    Sep

  • 02

    Oct

  • 28

    Oct

  • 29

    Oct

PEP PepsiCo
$114.83

-0.15 (-0.13%)

08/14/18
EVER
08/14/18
NO CHANGE
EVER
BodyArmor stake positive for Coca-Cola, negative for Pepsi, says Evercore
Evercore ISI analyst Robert Ottenstein views Coca-Cola's stake in BodyArmor as a "clear positive" for the company and a "clear negative" for both PepsiCo (PEP) and Keurig Dr Pepper (KDP). Pepsi's Gatorade product is most at risk with Coca-Cola taking a stake in BodyArmor, and Keurig Dr Pepper "losses distribution of the product and any path to ownership it might have enjoyed," Ottenstein tells investors in a research note.
07/16/18
RBCM
07/16/18
NO CHANGE
Target $75
RBCM
Outperform
Monster Beverage price hike to come November 1st, says RBC Capital
RBC Capital analyst Nik Modi says his industry sources have confirmed that Monster Beverage (MNST) intends to raise its prices by 4.0-5.5% on November 1st depending on the pack size, which would be in line with the management's indication of pricing review made at the June shareholder meeting. The analyst keeps his Outperform rating and $75 price target on Monster, adding that Coca Cola (KO), PepsiCo (PEP) and Keurig Dr Pepper (KDP) will also likely make pricing changes in response over the coming months.
07/23/18
JEFF
07/23/18
NO CHANGE
Target $107
JEFF
Hold
Jefferies sees risk of near-term downside in PepsiCo shares
Jefferies analyst Kevin Grundy sees potential near-term downside in shares of PepsiCo. Despite fundamental challenges and weak earnings quality, PepsiCo's "relative multiple remains elevated," Grundy tells investors in a research note. The analyst is "negatively biased" toward PepsiCo and reiterates a Hold rating on the shares with a $107 price target.
07/24/18
RHCO
07/24/18
NO CHANGE
Target $110
RHCO
Hold
PepsiCo price target raised to $110 from $105 at SunTrust
SunTrust analyst William Chappell raised his price target on PepsiCo to $110 to account for gains related to the impact of refranchising transactions, which he expects to support the company's high-single-digit EPS growth trend going forward. The analyst also keeps his Hold rating on PepsiCo as the stock is "fairly valued", with the company's Beverage business trading in line with peers and the Food business trading at the high end of its large-cap snack food peer range.
SODA Acquired by PEP
$142.14

12.25 (9.43%)

04/04/18
04/04/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. AT&T (T) initiated with a Buy at Spin-Off Research. 2. Spotify (SPOT) initiated with a Hold at Gabelli. 3. Wix.com (WIX) initiated with an Outperform at William Blair. 4. SodaStream (SODA) initiated with a Buy at B. Riley FBR. 5. Booking Holdings (BKNG) initiated with an Outperform at Wedbush while Expedia (EXPE), TripAdvisor (TRIP), and Trivago (TRVG) were initiated with a Neutral. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/03/18
RILY
04/03/18
INITIATION
Target $110
RILY
Buy
SodaStream initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Jeff Van Sinderen started SodaStream with a Buy rating and $110 price target. The analyst sees growth opportunities both in the U.S. and abroad.
09/25/17
SUSQ
09/25/17
NO CHANGE
Target $90
SUSQ
Positive
SodaStream price target raised to $90 from $79 at Susquehanna
Susquehanna analyst Pablo Zuanic raised his price target on SodaStream to $90 from $79 after meetings with the company, during which it said it is adding about 1M households per year to its platform. He said those numbers could prove to be conservative given its plans to triple its penetration in Germany and a reinvigorated push in the U.S. He sees improved economics, including higher machine margins, lower customer acquisition costs, new plant efficiencies, and improved EBIT. Zuanic reiterated his Positive rating on SodaStream shares.
TSLA Tesla
$308.50

3.17 (1.04%)

08/20/18
SBSH
08/20/18
NO CHANGE
SBSH
Neutral
Tesla may be wise to try equity capital raise sooner than later, says Citi
Citi analyst Itay Michaeli said he doesn't think Tesla has necessarily entered a "spiral" of declining confidence that could put its financial position into distress, but he thinks it would be wise for the company to at least try to raise significant new equity capital sooner rather than later if a go-private deal is looking less likely. If management doesn't see such a capital raise as necessary, he believes a "mid-quarter" update of some sort would be helpful given the heightened focus on its balance sheet that recent events have created. The analyst, who keeps a Neutral rating on Tesla shares, thinks a call on the stock requires a "high degree of conviction in either direction" given the potential for extreme outcomes.
08/20/18
08/20/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. JPMORGAN CUTS TESLA PRICE TARGET: JPMorgan analyst Ryan Brinkman reduced his price target on Underweight-rated Tesla (TSLA) back to $195 from $308, telling investors that he is reverting back to valuing shares on the basis of fundamentals alone. While Brinkman said that Tesla "does appear to be exploring a going private transaction," he believes that such a process appears "much less developed" than he had earlier presumed and is "more along the lines of high level intention," suggesting formal incorporation into his valuation analysis "seems premature." NIKE UPGRADED AT TWO FIRMS: Piper Jaffray analyst Erinn Murphy upgraded Nike (NKE) to Overweight from Neutral and raised her price target for shares to $93 from $72, telling investors she believes the risk profile of owning Nike shares has "considerably diminished" and sees Nike moving from downward EPS revisions to upward revisions supported by a stabilizing North America landscape, strong margin and sales drivers and improving brand momentum. Susquehanna analyst Sam Poser upgraded Nike to Positive from Neutral. The analyst cited its market share gains, and gains within the family footwear channel specifically, due to improved product offerings and product flow. He raised his price target to $93 from $78 on Nike shares. QUALCOMM UPGRADED TO BUY: Rosenblatt analyst Jun Zhang upgraded Qualcomm (QCOM) to Buy from Neutral and increased its price target to $70 from $57 citing benefits from 5G smartphone growth over the next few years, Zhang said Qualcomm's 5G RF module is better positioned than their 4G product and should continue to gain share in the high-end market due to MediaTek's smartphone chipset roadmap losing traction. BLOOM ENERGY INITIATIONS ALL OVER MAP: Morgan Stanley analyst Stephen Byrd started Bloom Energy (BE) with an Overweight rating and $30 price target, calling the company "a true disruptor" that is revolutionizing on-site power with its natural gas fuel cell systems. Credit Suisse analyst Michael Weinstein started Bloom Energy with a Neutral rating and $24 price target. After a nearly 80% jump off the $15 IPO, the analyst believes that current pricing captures a fair balance between the risk of executing continued cost reductions and the possible upside from accelerating sales growth once the investment tax credit sunsets in 2023. BofA/Merrill analyst Julien Dumouln-Smith initiated Bloom Energy with an Underperform and $19 price target citing high expectations and execution risks over costs and deployment.
08/20/18
JPMS
08/20/18
NO CHANGE
Target $195
JPMS
Tesla price target cut to $195 from $308 at JPMorgan
JPMorgan analyst Ryan Brinkman reduced his price target on Underweight-rated Tesla back to $195 from $308, telling investors that he is reverting back to valuing shares on the basis of fundamentals alone. Brinkman says that his interpretation of events leads him to believe that funding was not secured for a going private transaction, nor was there any formal proposal. While Brinkman says that Tesla "does appear to be exploring a going private transaction," he believes that such a process appears "much less developed" than he had earlier presumed and is "more along the lines of high level intention," suggesting formal incorporation into his valuation analysis "seems premature."
08/16/18
EVER
08/16/18
NO CHANGE
Target $301
EVER
In Line
After visiting Tesla's Freemont facility, Evercore ISI says Model 3 'on track'
Evercore ISI analyst George Galliers said he is a bit more positive on Tesla following his trip to the company's Freemont facility, stating that Tesla "seems well on the way" to achieving steady production of 5,000 to 6,000 Model 3 units per week and that reaching 7,000 to 8,000 units per week seems "well within reach." Following the trip, he said the Model 3 looks to be "on track" and while he continues to forecast second half Model 3 production of 123,000 units, Galliers now believes his estimate could be 4%-7% too low. He maintains an In Line rating on Tesla shares with a $301 price target.
LCI Lannett
$5.30

-8.2 (-60.74%)

08/20/18
08/20/18
DOWNGRADE

Market Perform
Lannett downgraded to Market Perform as JSP walks away from renewal at Raymond James
As previously reported, Raymond James analyst Elliot Wilbur downgraded Lannett to Market Perform from Outperform after Jerome Stevens terminated its strategic distribution agreement with the company, a deal that provided Lannett with several key products but mainly levothyroxine, which is expected to account for 35% of FY18 sales and 44% of gross profit. From a monetary perspective, the analyst believes it makes "zero sense" why JSP would walk away from the deal, inflicting significant damage on its own holdings of Lannett shares. This suggests either JSP has no confidence in the recovery value of its holdings from current levels or has sold down or hedged a substantial portion of its holdings despite prior representations from Lannett management to the contrary, Wilbur contends.
08/20/18
BMOC
08/20/18
NO CHANGE
BMOC
Market Perform
Lannett price target lowered to $8 from $19 at BMO Capital
BMO Capital analyst Gary Nachman said JSP's decision to not renew its agreement with Lannett (LCI) and go with Amneal Pharmaceuticals (AMRX) is an "unfortunate development" that impacts three products, including Levothyroxine, which accounts for about 35-40% of Lannett revenue and is "very profitable." He lowered his estimates "significantly" due to this "major setback" and cut his price target on Lannett shares to $8 from $19 while maintaining a Market Perform rating on the shares.
08/20/18
08/20/18
DOWNGRADE
Target $7

Hold
Lannett downgraded to Hold on end of JSP relationship at Craig-Hallum
As previously reported, Craig-Hallum analyst Matt Hewitt downgraded Lannett to Hold from Buy, stating that the ending of the company's "fruitful long-time partnership" with Jerome Stephens Pharmaceuticals is a "significant disappointment" that creates a noticeable cash flow void and creates a risk that the company's debt gets refinanced at higher interest rates. Separate from the JSP announcement, Lannett also preannounced Q4 results that were below consensus, noted Hewitt, who lowered his price target on the stock to $7 from $32. Lannett shares, which were also downgraded earlier to Neutral from Buy at Roth Capital, are down $7.92, or 59%, to $5.58 in afternoon trading.
08/20/18
RAJA
08/20/18
DOWNGRADE
RAJA
Market Perform
Lannett downgraded to Market Perform from Outperform at Raymond James
TSN Tyson Foods
$63.40

1 (1.60%)

07/31/18
PIPR
07/31/18
NO CHANGE
Target $70
PIPR
Overweight
Tyson Foods price target lowered to $70 from $92 at Piper Jaffray
Piper Jaffray analyst Michael Lavery lowered his price target for Tyson Foods to $70 after the company reduced its outlook for fiscal 2018. Oversupply in protein are driving down selling prices faster than costs are falling and tariffs are driving down export demand, Lavery tells investors in a research note. Tyson has some partially offsetting cost favorability from lower hog and feed costs, however, the analyst adds. He keeps an Overweight rating on Tyson Foods.
08/07/18
BMOC
08/07/18
NO CHANGE
Target $82
BMOC
Outperform
Tyson Foods price target lowered to $82 from $89 at BMO Capital
BMO Capital analyst Kenneth Zaslow lowered his price target on Tyson Foods to $82 after its Q3 earnings missed consensus amid softer chicken margins, while the management maintained a "conservative" FY18 EPS outlook to avoid any more negative surprises and to reflect the market's "immediate conditions". The analyst maintains his Outperform rating longer term, stating that the company is positioned for a sustainable earnings growth on favorable underlying fundamentals, and that Tyson Foods stock "deserves a premium multiple to its history, in light of its structural improvements and capital allocation".
08/07/18
RBCM
08/07/18
NO CHANGE
Target $77
RBCM
Sector Perform
Tyson Foods price target lowered to $77 from $82 at RBC Capital
RBC Capital analyst David Palmer lowered his price target on Tyson Foods to $77 and kept his Sector Perform rating, citing "greater than anticipated softness in chicken demand" leading to below-trend margins. The analyst also cites increased competition in pork processing and tariff uncertainty from the U.S. trade friction with Mexico and China potentially resulting in further margin compression. Palmer still expects profitability in the beef business to be above normal ranges and profit growth in Prepared Foods segment coming from the Advance Pierre synergies.
07/30/18
SPHN
07/30/18
NO CHANGE
Target $73
SPHN
Overweight
Tyson Foods price target lowered to $73 from $82 at Stephens
Stephens analyst Farha Aslam lowered her price target on Tyson Foods shares to $73 after the company cut its FY18 adjusted EPS view to $5.70-$6.00 from $6.55-$6.70, stating that commodity fundamentals are weak but she believes the valuation is attractive with the shares trading at a 5-year low in terms of valuation compared to forward earnings. Tyson is making operational improvements that should support the company's long-term earnings growth, said Aslam, who keeps an Overweight rating on Tyson shares.
MCD McDonald's
$161.67

0.51 (0.32%)

08/02/18
08/02/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. OPCO UPGRADES TESLA TO OUTPERFORM: Oppenheimer analyst Colin Rusch upgraded Tesla (TSLA) to Outperform from Perform with a price target of $385 following Wednesday night's Q2 results. Gross margin performance on the Model 3 will carry the stock over the next 12-plus months, Rusch said. With higher volumes and slower spending, Tesla has "reached a critical inflection point in its development," the analyst added. He noted that despite some recent price pressure, Model S and X average selling prices have remained at relatively elevated levels. Rusch said he would not be surprised to see a similar scenario play out for the Model 3. SUNTRUST STARTS MAGNOLIA WITH A BUY: SunTrust analyst Neal Dingmann initiated Magnolia Oil & Gas (MGY) with a Buy rating and a price target of $18. The analyst noted that the company is a "unique E&P" with top-tier assets in the Eagle Ford and low leverage on its balance sheet. Dingmann is also positive on Magnolia's strong free cash flow and experience in transactions management. MORGAN STANLEY SAYS FERRARI SELLOFF A BUYING OPPORTUNITY: Morgan Stanley analyst Adam Jonas upgraded Ferrari (RACE) to Equal Weight from Underweight, stating that the stock's 10% selloff presents an opportunity to increase exposure with the stock now reflecting a more balanced assessment of the risks to the 2022 EUR2B EBITDA target. He raised his price target on Ferrari shares to $120 from $110. BARCLAYS CUTS HANESBRANDS: Barclays analyst Chethan Mallela downgraded Hanesbrands (HBI) to Equal Weight and lowered his price target for the shares to $19 from $22. The analyst sees a lack of visibility into the second half of the year following the company's Q2 results. WENDY'S CUT TO NEUTRAL: Kalinowski Equity Research analyst Mark Kalinowski downgraded Wendy's to Neutral from Buy ahead of the Q2 report on August 7. Kalinowski' checks indicate July same-store sales growth is trending below the 1.5% level and were the worst checks since February 2012. As a result, the analyst lowered his Q3 system-wide North American same-store sales growth forecast to a new consensus low of 1.5 from 2.5%. Kalinowski believes McDonald's (MCD) and Burger King, owned by Restaurant Brands (QSR), could become more "assertive" on promotions and discounting, making it difficult for Wendy's to right the ship.
07/27/18
JPMS
07/27/18
NO CHANGE
Target $182
JPMS
Overweight
McDonald's post-earnings selloff overdone, says JPMorgan
JPMorgan analyst John Ivankoe views the post-earnings selloff in shares of McDonald's as overdone. Drivers are in place to provide "comp support and outperformance in the U.S. for the years to come," Ivankoe tells investors in a research note following the company's Q2 results. He adds that international growth remains high at McDonald's.
07/26/18
SPHN
07/26/18
NO CHANGE
Target $165
SPHN
Equal Weight
McDonald's price target lowered to $165 after earnings at Stephens
Stephens analyst Will Slabaugh noted that McDonald's global SSS growth of 4% beat his and consensus expectations, but its U.S. SSS growth of 2.6% was below the consensus view of 3.1%. He believes drive thru execution hurt performance and value continued to modestly underperform, adding that he believes the company is in a more normalized range for U.S. comps. Slabaugh keeps an Equal Weight rating on McDonald's shares and trimmed his price target on the stock to $165 from $170.
08/08/18
WELS
08/08/18
NO CHANGE
Target $185
WELS
Outperform
McDonald's price target raised to $185 from $180 at Wells Fargo
Wells Fargo analyst Jon Tower raised his price target for McDonald's to $185 from $180 as he believes it will see an acceleration in 2H18 U.S. same-store sales predicated on the combination of abating Experience of the Future headwinds and increased deals and evolved value messaging. The analyst sees this same-store sales growth further picking up steam in 2019 with the EOTF program flipping from a same-store sales headwind to a tailwind, the frequency and depth of value deals remaining high and McDonald's making a small, but powerful change to its delivery program. He reiterates an Outperform rating on the shares.
CBPO China Biologic
$99.83

7.77 (8.44%)

03/02/18
DBAB
03/02/18
NO CHANGE
Target $105
DBAB
Buy
China Biologic shares 'cheap' at current levels, says Deutsche Bank
Deutsche Bank analyst Jack Hu says that while near-term pressure on shares of China Biologic Products, the stock is "cheap" at current levels. The analyst lowered his price target for the shares to $105 and $116 and keeps a Buy rating on China Biologic.
05/14/18
JEFF
05/14/18
DOWNGRADE
JEFF
Hold
China Biologic downgraded to Hold from Buy at Jefferies
05/14/18
JEFF
05/14/18
DOWNGRADE
Target $83
JEFF
Hold
China Biologic downgraded to Hold from Buy at Jefferies
As previously reported, Jefferies analyst Johnny Kin Man Wong downgraded China Biologic Products to Hold from Buy and cut his price target on shares to $83 from $97 citing a lack of visibility ahead. In a research note to investors, the analyst said healthcare reforms are likely to impact the company more harshly than originally expected as hospitals continue to hold back from ordering despite what he feels is healthy end demand.
08/06/18
FBCO
08/06/18
DOWNGRADE
FBCO
Neutral
China Biologic downgraded to Neutral from Outperform at Credit Suisse
NWSA News Corp.
$13.57

-0.33 (-2.37%)

08/20/18
08/20/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Constellation Brands (STZ, STZ.B) downgraded to Negative from Neutral at Susquehanna with analyst Pablo Zuanic citing valuation. 2. Infosys (INFY) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Parag Gupta citing a belief that concerns around senior management exits will remain an overhang on the stock. 3. YogaWorks (YOGA) downgraded to Market Perform from Outperform at Cowen with analyst Oliver Chen saying he sees risk to visitation and revenue trends with the company's medium-term priorities of pulling back on promotions and marketing. 4. News Corp. (NWSA) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Andrew McLeod saying its Australian payTV unit, Foxtel, will launch a new OTT sports service by the end of 2018, which presents the "obvious risk" that its existing subscriber base and high ARPU will come under pressure. 5. Park Hotels & Resorts (PK) downgraded to In Line from Outperform at Evercore ISI. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/20/18
08/20/18
DOWNGRADE
Target $12.5

Underweight
News Corp. downgraded to Underweight on Foxtel OTT risks at Morgan Stanley
As previously reported, Morgan Stanley analyst Andrew McLeod downgraded News Corp. to Underweight from Equal Weight, noting that its Australian payTV unit, Foxtel, will launch a new OTT sports service by the end of 2018, which presents the "obvious risk" that its existing subscriber base and high ARPU will come under pressure. While McLeod believes it's a risk that should be taken because "history says that if Foxtel doesn't disrupt itself, someone else will," he also cut his estimates and value for the unit. McLeod lowered his price target on News Corp. shares to $12.50 from $17.00.
08/20/18
MSCO
08/20/18
DOWNGRADE
MSCO
Underweight
News Corp. downgraded to Underweight from Equal Weight at Morgan Stanley
03/15/18
LOOP
03/15/18
INITIATION
Target $17
LOOP
Hold
News Corp. initiated with a Hold at Loop Capital
Loop Capital analyst Alan Gould started News Corp. with a Hold rating and $17 price target. The analyst cites valuation for the Hold rating and believes the Foxtel transaction could weigh on the company's near-term growth rate.
NKE Nike
$82.16

2.43 (3.05%)

08/20/18
SUSQ
08/20/18
UPGRADE
SUSQ
Positive
Nike upgraded to Positive from Neutral at Susquehanna
08/20/18
08/20/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Nike (NKE) upgraded to Positive from Neutral at Susquehanna and to Overweight from Neutral at Piper Jaffray. 2. Qualcomm (QCOM) upgraded to Buy from Neutral at Rosenblatt with analyst Jun Zhang citing benefits from 5G smartphone growth over the next few years. 3. Flir Systems (FLIR) upgraded to Outperform from Market Perform at William Blair with analyst Louie DiPalma he believes, in the near-term, Flir's enhanced automation and software capabilities are rendering its sensors more powerful and driving adoption. Additionally, DiPalma believes thermal sensors will be common in autonomous vehicles over the longer term, which could be a major source of long-term upside. 4. RBS (RBS) upgraded to Buy from Neutral at Citi. 5. Terex (TEX) upgraded to Neutral from Underperform at Baird with analyst Mig Dobre citing its recent pullback and multiple compression as well as its upcoming investors day. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/20/18
SUSQ
08/20/18
UPGRADE
Target $93
SUSQ
Positive
Nike upgraded to Positive at Susquehanna
As reported previously, Susquehanna analyst Sam Poser upgraded Nike to Positive from Neutral. The analyst cited its market share gains and gains within the family footwear channel. The gains are due to improved product offerings and product flow, putting the company on pace to meet its 2023 $50B revenue target, said Poser. He raised his price target to $93 from $78 on Nike shares.

TODAY'S FREE FLY STORIES

TEVA

Teva

$10.86

-0.18 (-1.63%)

12:11
05/26/19
05/26
12:11
05/26/19
12:11
Hot Stocks
Teva reaches $85M agreement with State of Oklahoma »

Teva Pharmaceuticals USA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESLT

Elbit Systems

$141.85

1.33 (0.95%)

12:08
05/26/19
05/26
12:08
05/26/19
12:08
Hot Stocks
Elbit Systems awarded $127M contract to provide tactical radio system »

Elbit Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

ADM

Archer Daniels

$39.17

-0.03 (-0.08%)

12:05
05/26/19
05/26
12:05
05/26/19
12:05
Hot Stocks
Archer Daniels expands recall of Baker's Corner All Purpose Flour 5lb bags »

ADM Milling is recalling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

JCP

J.C. Penney

$0.93

0.022 (2.42%)

, DDS

Dillard's

$56.57

0.25 (0.44%)

13:29
05/25/19
05/25
13:29
05/25/19
13:29
Periodicals
Target stock triumphs in brutal week for retail, Barron's says »

Earnings season has been…

JCP

J.C. Penney

$0.93

0.022 (2.42%)

DDS

Dillard's

$56.57

0.25 (0.44%)

KSS

Kohl's

$51.11

-0.04 (-0.08%)

JWN

Nordstrom

$33.50

-0.31 (-0.92%)

M

Macy's

$21.00

-0.27 (-1.27%)

TGT

Target

$81.57

2.17 (2.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

JPM

JPMorgan

$109.78

1.14 (1.05%)

, AKZOY

AkzoNobel

$0.00

(0.00%)

13:24
05/25/19
05/25
13:24
05/25/19
13:24
Periodicals
Microsoft, JPMorgan among dividend champions, Barron's says »

Among the companies that…

JPM

JPMorgan

$109.78

1.14 (1.05%)

AKZOY

AkzoNobel

$0.00

(0.00%)

XOM

Exxon Mobil

$74.12

0.33 (0.45%)

MSFT

Microsoft

$126.23

0.04 (0.03%)

CMWAY

Commonwealth Bank of Australia

$0.00

(0.00%)

SIEGY

Siemens

$0.00

(0.00%)

T

AT&T

$32.29

0.15 (0.47%)

RDS.A

Royal Dutch Shell

$63.29

0.84 (1.35%)

RHHBY

Roche

$0.00

(0.00%)

NVS

Novartis

$87.49

3.03 (3.59%)

BHP

BHP Group

$52.47

1.18 (2.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 29

    May

  • 29

    May

  • 31

    May

  • 03

    Jun

  • 03

    Jun

  • 03

    Jun

  • 05

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 11

    Jun

  • 12

    Jun

  • 20

    Jun

  • 23

    Jun

  • 16

    Jul

  • 24

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 02

    Sep

  • 04

    Nov

GM

General Motors

$35.13

0.01 (0.03%)

, TSLA

Tesla

$190.80

-4.7 (-2.40%)

13:19
05/25/19
05/25
13:19
05/25/19
13:19
Periodicals
Tesla stock in trouble, Barron's says »

Tesla (TSLA) stock is the…

GM

General Motors

$35.13

0.01 (0.03%)

TSLA

Tesla

$190.80

-4.7 (-2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

  • 05

    Jun

  • 11

    Jun

  • 01

    Aug

RNLSY

Renault

$0.00

(0.00%)

13:14
05/25/19
05/25
13:14
05/25/19
13:14
Periodicals
Renault stock may rally, Barron's says »

Shares of French auto…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMC

FMC Corporation

$70.88

-0.47 (-0.66%)

, DWDP

DowDuPont

$31.10

0.16 (0.52%)

13:11
05/25/19
05/25
13:11
05/25/19
13:11
Periodicals
DowDuPont spinoff a new agriculture stock, FMC safer bet, Barron's says »

The crop-protection and…

FMC

FMC Corporation

$70.88

-0.47 (-0.66%)

DWDP

DowDuPont

$31.10

0.16 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 25

    Jun

MGM

MGM Resorts

$25.55

0.19 (0.75%)

13:03
05/25/19
05/25
13:03
05/25/19
13:03
Periodicals
MGM Resorts looks like an attractive gambling play, Barron's says »

MGM Resorts (MGM) stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

PYPL

PayPal

$109.82

-0.09 (-0.08%)

, AXP

American Express

$119.52

1.07 (0.90%)

12:30
05/25/19
05/25
12:30
05/25/19
12:30
Periodicals
Big tech failed to dethrone credit cards, Barron's says »

Rather than being cut out…

PYPL

PayPal

$109.82

-0.09 (-0.08%)

AXP

American Express

$119.52

1.07 (0.90%)

MA

MasterCard

$251.40

1.57 (0.63%)

V

Visa

$162.72

1.2 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 03

    Jun

  • 05

    Jun

  • 06

    Jun

  • 11

    Jun

  • 25

    Jun

  • 13

    Nov

GOOG

Alphabet

$1,132.99

-7.56 (-0.66%)

, GOOGL

Alphabet Class A

$1,138.90

-5.98 (-0.52%)

07:20
05/25/19
05/25
07:20
05/25/19
07:20
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

GOOG

Alphabet

$1,132.99

-7.56 (-0.66%)

GOOGL

Alphabet Class A

$1,138.90

-5.98 (-0.52%)

MSFT

Microsoft

$126.23

0.04 (0.03%)

AMBA

Ambarella

$38.28

1.07 (2.88%)

ON

ON Semiconductor

$17.68

-0.235 (-1.31%)

NKE

Nike

$82.12

-0.51 (-0.62%)

ADDYY

Adidas

$0.00

(0.00%)

UAA

Under Armour

$23.54

0.075 (0.32%)

UA

Under Armour

$20.91

0.08 (0.38%)

FL

Foot Locker

$44.39

-8.455 (-16.00%)

VMC

Vulcan Materials

$126.28

1.25 (1.00%)

FLR

Fluor

$29.04

0.18 (0.62%)

ACM

Aecom

$31.56

-0.03 (-0.09%)

X

U.S. Steel

$13.63

-0.08 (-0.58%)

AKS

AK Steel

$2.00

-0.155 (-7.21%)

NUE

Nucor

$51.12

-0.27 (-0.53%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$12.85

0.11 (0.86%)

F

Ford

$9.83

-0.02 (-0.20%)

GM

General Motors

$35.13

0.01 (0.03%)

HMC

Honda

$25.45

0.175 (0.69%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$118.54

1.16 (0.99%)

VWAGY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 03

    Jun

  • 03

    Jun

  • 04

    Jun

  • 04

    Jun

  • 05

    Jun

  • 06

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 12

    Jun

  • 13

    Jun

  • 19

    Jun

  • 19

    Jun

  • 23

    Jun

  • 09

    Jul

  • 24

    Jul

  • 31

    Jul

  • 01

    Aug

  • 06

    Aug

  • 23

    Oct

  • 27

    Oct

UBER

Uber

$41.40

0.94 (2.32%)

17:49
05/24/19
05/24
17:49
05/24/19
17:49
Hot Stocks
Uber board director Ryan Graves intends to resign »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

APTO

Aptose Biosciences

$2.01

0.03 (1.52%)

17:46
05/24/19
05/24
17:46
05/24/19
17:46
Syndicate
Aptose Biosciences files for $40M at-the-market common stock offering »

Piper Jaffray and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

TRNX

Taronis Technologies

$0.48

0.004 (0.84%)

17:26
05/24/19
05/24
17:26
05/24/19
17:26
Syndicate
Breaking Syndicate news story on Taronis Technologies »

Taronis Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:25
05/24/19
05/24
17:25
05/24/19
17:25
Hot Stocks
U.S. Energy discloses Nasdaq notice regarding delayed 10-Q filing »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

17:22
05/24/19
05/24
17:22
05/24/19
17:22
Periodicals
Apple sued over allegedly selling users' iTunes data, Bloomberg says »

Apple is being sued by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SPCB

SuperCom

$1.17

-0.005 (-0.43%)

17:21
05/24/19
05/24
17:21
05/24/19
17:21
Hot Stocks
SuperCom discloses Nasdaq notice regarding delayed 20-F filing »

SuperCom received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:20
05/24/19
05/24
17:20
05/24/19
17:20
Hot Stocks
U.S. Energy receives noncompliance notice from Nasdaq »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:18
05/24/19
05/24
17:18
05/24/19
17:18
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:17
05/24/19
05/24
17:17
05/24/19
17:17
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$87.49

3.03 (3.59%)

, QGEN

Qiagen

$38.22

-0.255 (-0.66%)

16:57
05/24/19
05/24
16:57
05/24/19
16:57
Hot Stocks
Qiagen launches diagnostic for PIK3CA biomarkers in breast cancer »

Qiagen (QGEN) announced…

NVS

Novartis

$87.49

3.03 (3.59%)

QGEN

Qiagen

$38.22

-0.255 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 31

    May

  • 20

    Jun

  • 06

    Aug

AVH

Avianca

$3.96

0.91 (29.84%)

16:56
05/24/19
05/24
16:56
05/24/19
16:56
Periodicals
ANAC suspends flights, operations of Avianca Brasil, Reuters reports »

Brazil's ANAC said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

16:53
05/24/19
05/24
16:53
05/24/19
16:53
Periodicals
Apple acquires startup Tueo Health, CNBC reports »

Apple has bought Tueo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SHSP

SharpSpring

$16.37

-0.24 (-1.44%)

16:52
05/24/19
05/24
16:52
05/24/19
16:52
Syndicate
Breaking Syndicate news story on SharpSpring »

SharpSpring files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

CREG

China Recycling Energy

$0.48

0.005 (1.05%)

16:41
05/24/19
05/24
16:41
05/24/19
16:41
Syndicate
Breaking Syndicate news story on China Recycling Energy »

China Recycling Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.